EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin

Irina Tolmacheva, Yulia Beloglazova iD, Mikhail Nazarov, Olga Gagarskikh iD, Victoria Grishko iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24129863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irina Tolmacheva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Perm Federal Scientific Centre, Institute of Technical Chemistry UB RAS, Academician Korolev St. 3, 614013 Perm, Russia. Hauptthemen laut MEDLINE: Doxorubicin, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) is a common phenomenon in clinical oncology, whereby cancer cells become resistant to chemotherapeutic drugs. A common MDR mechanism is the overexpression of ATP-binding cassette efflux transporters in cancer cells, with P-glycoprotein (P-gp) being one of them. New 3,4-seco-lupane triterpenoids, and the products of their intramolecular cyclization with the removed 4,4-gem-dimethyl group, were synthesized by the selective transformations of the A-ring of dihydrobetulin. Among the semi-synthetic derivatives, the MT-assay-enabled methyl ketone 31 (MK), exhibiting the highest cytotoxicity (0.7–16.6 µM) against nine human cancer cell lines, including P-gp overexpressing subclone HBL-100/Dox, is identified. In silico, MK has been classified as a potential P-gp-inhibitor; however, the Rhodamine 123 efflux test, and the combined use of P-gp-inhibitor verapamil with MK in vitro, showed the latter to be neither an inhibitor nor a substrate of P-gp. As the studies have shown, the cytotoxic effect of MK against HBL-100/Dox cells is, arguably, induced through the activation of the ROS-mediated mitochondrial pathway, as evidenced by the positive Annexin V-FITC staining of apoptotic cells, the cell cycle arrest in the G0/G1 phase, mitochondrial dysfunction, cytochrome c release, and the activation of caspase-9 and -3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinAntineoplastic AgentsHumansDrug Resistance, NeoplasmDrug Resistance, MultipleATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily BATP-Binding Cassette TransportersCell Line, Tumor

Stichwörter der Autor:innen

P-glycoproteinROSapoptosiscytotoxicitydihydrobetulindrug resistanceintrinsic pathwaytriterpenoids

Substanzen

DoxorubicinAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily BATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Perm Federal Scientific Centre, Institute of Technical Chemistry UB RAS, Academician Korolev St. 3, 614013 Perm, Russia.

ORCID-Profile: Yulia Beloglazova, Olga Gagarskikh, Victoria Grishko

Förderung

  • Russian Science Foundation

Zitieren

APA

Tolmacheva, I., Beloglazova, Y., Nazarov, M., Gagarskikh, O., & Grishko, V. (2023). Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129863

Vancouver

Tolmacheva I, Beloglazova Y, Nazarov M, Gagarskikh O, Grishko V. Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129863

BibTeX
@article{Tolmacheva2023,
  author = {Tolmacheva, Irina and Beloglazova, Yulia and Nazarov, Mikhail and Gagarskikh, Olga and Grishko, Victoria},
  title = {Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24129863}
}
Kostenlos starten →